Prescription of acid-suppressing drugs in relation to endoscopic diagnosis: A rcord-linkage study

Alimentary Pharmacology and Therapeutics

Volumn 13, Issue 3, 1999, Pages 397-405

  Prach, A T ^a   Mcgilchrist, M M ^a   Murray, F E ^a   Johnston, D A ^a   Macdonald, T M ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CIMETIDINE; FAMOTIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; MISOPROSTOL; NIZATIDINE; RANITIDINE; STOMACH SECRETION INHIBITOR;

ARTICLE; BARRETT ESOPHAGUS; DATA BASE; DRUG MONITORING; DRUG PREFERENCE; DRUG USE; DUODENITIS; DUODENUM; DYSPEPSIA; ENDOSCOPE; ESOPHAGITIS; ESOPHAGUS; HUMAN; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PRESCRIPTION; PRIORITY JOURNAL; PYLORUS STENOSIS; STOMACH; STOMACH ULCER;

AGED; ANTACIDS; DRUG UTILIZATION; ENDOSCOPY, GASTROINTESTINAL; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; MALE; MEDICAL RECORD LINKAGE; MIDDLE AGED; PEPTIC ULCER; PRESCRIPTIONS, DRUG;

EID: 0033067491     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1999.00463.x     Document Type: Article

References (26)

1. 1 Kahn K, Greenfield S. Endoscopy in the evaluation of dyspepsia. Ann Int Med 1985; 102: 266-9.
2. 2 Colin-Jones DG. Management of dyspepsia: report of a working-party. Lancet 1988; i: 576-9.
3. 3 British Society of Gastroenterology. Dyspepsia Management Guidelines. London, 1996.
4. 4 MacDonald TM, McDevitt DG. The Tayside Medicines Monitoring Unit (MEMO). In: Strom BL, ed. Pharmacoepidemiology, 2nd edn. Chichester, UK: Wiley, 1994: 245-55.
5. 5 Evans JMM, McDevitt DG, MacDonald TM. The Tayside Medicines Monitoring Unit (MEMO): a record-linkage system for pharmacovigilance. Pharm Med 1995; 9: 177-84.
6. 6 British Medical Association, the Royal Pharmaceutical Society of Great Britain. British National Formulary, Number 32. London: British Medical Association, and Oxford: The Pharmaceutical Press, 1996.
7. 7 Armitage P, Berry G. Statistical Methods in Medical Research, 3rd edn. Oxford: Blackwell Scientific Publications, 1994: 118-25.
8. 8 Petersen H. The clinical significance of hiatus hernia. Scand J Gastroenerol 1995; 30(Suppl. 211): 19-20.
9. 9 Price AB. The Sydney System: histologic division. J Gastroenterol Hepatol 1991; 6: 207-8.
10. 10 Tytgat GNJ, Noach LA, Rauws EAJ. Is gastroduodenitis a cause of chronic dyspepsia? Scand J Gastroenterol 1991; 26(Suppl. 182): 33-9.
11. 11 Lambert JR. The role of Helicobacter pylori in nonulcer dyspepsia: a debate - for. Gastroenterol Clin N Am 1993; 22: 141-51.
12. 12 Talley NJ. The role of Helicobacter pylori in nonulcer dyspepsia: a debate - against. Gastroenterol Clin N Am 1993; 22: 153-67.
13. 13 Parsonnet J. Helicobacter pylori. Infect Dis Clin N Am 1998; 12: 185-97.
14. 14 Skoutakis VA, Joe RH, Hara DS. Comparative role of omeprazole in the treatment of gastroesophageal reflux disease. Ann Pharmacother 1995; 29: 1252-62.
15. 15 Baron TH, Richter JE. The use of esophageal function tests. Adv Intern Med 1993; 38: 361-86.
16. 16 Hansen JM, Bytzer P, Schaffalitzky de Muckadell OB. Placebo controlled trial of cisapride and nizatidine in unselected patients with functional dyspepsia. Am J Gastroenterol 1998; 93: 368-74.
17. 17 Farup PG, Wetterhus S, Osnes M, Ulshagen K. Ranitidine effectively relieves symptoms in a subset of patients with functional dyspepsia. Scand J Gastroenterol 1997; 32: 755-9.
18. 18 Ryder SD, O'Reilly S, Miller RJ, Ross J, Jacyna MR, Levi AJ. Long term acid suppressing treatment in general practice. Br Med J 1994; 308: 827-30.
19. 19 Roberts SJ, Bateman DN. Prescribing of antacids and anti-secretory drugs in primary care in the north of England. Aliment Pharmacol Ther 1995; 9: 137-43.
20. 20 Goudie BM, McKenzie PE, Cipriano J, Griffin EM, Murray FE. Repeat prescribing of ulcer healing drugs in general practice - prevalence and underlying diagnosis. Aliment Pharmacol Ther 1996; 10: 147-50.
21. 21 Hungin APS, Thomas PR, Bramble MG, et al. What happens to patients following open access gastroscopy? An outcome study from general practice. Br J Gen Pract 1994; 44: 519-21.
22. 22 Bodger K, Daly MJ, Heatley RV. Prescribing patterns for dyspepsia in primary care: a prospective study of selected general practitioners. Aliment Pharmacol Ther 1996; 10: 889-95.
23. 2-blocker therapy or prompt endoscopy in management of dyspepsia. Lancet 1994; 343: 811-16.
24. 24 NIH Consensus Development Panel on Helicobacter pylori in peptic ulcer disease. Helicobacter pylori in peptic ulcer disease. J Am Med Assoc 1994; 272: 65-9.
25. 25 Talley NJ, Hunt RH. What role does Helicobacter pylori play in dyspepsia and non-ulcer dyspepsia. Arguments for H. pylori being associated with dyspeptic symptoms. Gastroenterol 1997; 113(Suppl. 6): 567-77.
26. 26 Labenz J, Blum AL, Bayerdörffer E, Meining A, Stolte M, Börsch G. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology 1997; 112: 1442-7.